2025. MOLECULAR DOCKING INVESTIGATION OF VANILLIN-SCHIFF BASES AS A ARABINOSYLTRANSFERASE-C INHIBITORS. Frontier in Medical and Health Research. 3, 5 (Jul. 2025), 1666–1673.